Sage Journals: Discover world-class research

Retricted access

Review article

First published 2020-10

Role of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura

Justin H Reid, Karin M Durant, Sheh-Li Chen [...]

Journal of Oncology Pharmacy Practice

Open access

Case report

First published 2026

Effectiveness of caplacizumab in the first-line treatment for acquired thrombotic thrombocytopenic purpura: single center experience

Kristina Maria Belakova, Renata Pizurova, Tomas Simurda [...]

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2023-11

Identify the influences of systemic lupus erythematosus on acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura using comprehensive bioinformatics analysis

Jian Zhang

Lupus

Retricted access

Research article

First published 2021-4

Characteristics Behaviors of Coagulation and Fibrinolysis Markers in Acquired Thrombotic Thrombocytopenic Purpura

Kazuya Sakai, Hideo Wada, Yuki Nakatsuka [...]

Journal of Intensive Care Medicine

Open access

Research article

First published 2017-6

Rituximab as first-line treatment for acquired thrombotic thrombocytopenic purpura

Haifei Chen, Ailin Fu, Jing Wang [...]

Journal of International Medical Research

Open access

Research article

First published 2019

Comparison of the Long-Term Remission of Rituximab and Conventional Treatment for Acquired Thrombotic Thrombocytopenic Purpura: A Systematic Review and Meta-Analysis

Weerapat Owattanapanich, Chompunut Wongprasert, Wannaphorn Rotchanapanya [...]

Clinical and Applied Thrombosis/Hemostasis

Open access

Review article

First published 2020

Caplacizumab in adult patients with acquired thrombotic thrombocytopenic purpura

Ashley Hanlon, Ara Metjian

Therapeutic Advances in Hematology

Retricted access

Letter

First published 2022-7

Case reports of acquired thrombotic thrombocytopenic purpura attributed to pembrolizumab

Peter J Gilbar, Marcus SR Dickey

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2021-3

New Therapeutic Targets and Treatment Options for Thrombotic Microangiopathy: Caplacizumab and Ravulizumab

Clement Chung

Annals of Pharmacotherapy

Retricted access

Case report

First published 2020-7

Pembrolizumab-induced thrombotic thrombocytopenic purpura

Marcus SR Dickey, Anant J Raina, Peter J Gilbar [...]

Journal of Oncology Pharmacy Practice

Search results